Fred Alger Management, LLC Adaptive Biotechnologies Corp Transaction History

Fred Alger Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $841,103 - $1.16 Million	-26,105 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $746,429 - $1.36 Million	-20,033 Reduced 43.42%	26,105 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $46,810 - $68,088	-1,040 Reduced 2.2%	46,138 $2.73 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $680,260 - $927,731	19,007 Added 67.47%	47,178 $2.29 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $199,600 - $387,040	8,000 Added 39.66%	28,171 $1.36 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $135,680 - $273,280	-8,000 Reduced 28.4%	20,171 $560,000
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $26.2 Million - $35 Million	-1,068,498 Reduced 97.43%	28,171 $843,000
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $17.8 Million - $31.5 Million	588,874 Added 115.97%	1,096,669 $33.9 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $20.5 Million - $24.5 Million	507,795 New	507,795 $24.5 Million

202

144M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.11B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.